BJGP Open (Jul 2018)

Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial

  • Marjolein JC Schot,
  • Ann Van den Bruel,
  • Berna DL Broekhuizen,
  • Jochen WL Cals,
  • Eveline A Noteboom,
  • Walter Balemans,
  • Rogier M Hopstaken,
  • Sanne van Delft,
  • Niek J de Wit,
  • Theo JM Verheij

DOI
https://doi.org/10.3399/bjgpopen18X101600
Journal volume & issue
Vol. 2, no. 3

Abstract

Read online

Background: Overprescription of antibiotics for lower respiratory tract infections (LRTIs) in children is common, partly due to diagnostic uncertainty, in which case the addition of point-of-care (POC) C-reactive protein (CRP) testing can be of aid. Aim: To assess whether use of POC CRP by the GP reduces antibiotic prescriptions in children with suspected non-serious LRTI. Design & setting: An open, pragmatic, randomised controlled trial in daytime general practice and out-of-hours services. Method: Children between 3 months and 12 years of age with acute cough and fever were included and randomised to either use of POC CRP or usual care. Antibiotic prescription rates were measured and compared between groups using generalising estimating equations. Results: There was no statistically significant reduction in antibiotic prescriptions in the GP use of CRP group (30.9% versus 39.4%; odds ratio [OR] 0.6; 95% confidence interval [CI] = 0.29 to 1.23). Only the estimated severity of illness was related to antibiotic prescription. Forty-six per cent of children had POC CRP levels <10mg/L. Conclusion: It is still uncertain whether POC CRP measurement in children with non-serious respiratory tract infection presenting to general practice can reduce the prescription of antibiotics. Until new research provides further evidence, POC CRP measurement in these children is not recommended.

Keywords